Search
Cryoport Inc
CYRXAdd to Watchlist
15.860USD
+0.160+1.02%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
799.38MMarket Cap
11.07P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+1.02%
5 Days
+2.19%
1 Month
-0.81%
6 Months
+65.21%
Year to Date
+65.21%
1 Year
+116.96%
Key Figures
15.660Open
16.650High
1.14MVolume
11.07P/E TTM
LossP/E Dynamic
--Dividend TTM
2.27%Turnover Ratio
15.700Prev. Close
15.585Low
13.95MTurnover
LossP/E Static
1.77P/B
0.00%Div Yield TTM
-5.01%ROA
15.29052wk High
0.96Volume Ratio
-122.76MNet Profit
50.20MShares
1.4325EPS TTM
1.87Beta
-10.98%ROE
5.31052wk Low
6.78%Amplitude
45.85%Gross Margin
799.38MMarket Cap
-0.07Reward/Risk
3.43%Risk Rate
TradingKey Stock Score of Cryoport Inc
Currency: USD Updated: 2026-07-01Key Insights
Cryoport Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 4 out of 78 in the Freight & Logistics Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 15.30.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cryoport Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Cryoport Inc Highlights
StrengthsRisks
Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PB is 1.77, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 49.22M shares, decreasing 18.53% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 25.00K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.66.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
15.300
Target Price
-2.55%
Upside Space
Cryoport Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Cryoport Inc Info
Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
Ticker SymbolCYRX
CompanyCryoport Inc
CEOShelton (Jerrell Wilson)
Websitehttps://www.cryoport.com/
Related Instruments
+2.12%
+1.90%
+1.68%
-0.76%
+0.27%
+0.47%
+1.40%
-0.67%
+0.63%
-0.63%
-1.96%
+0.22%
-1.81%
+0.93%
+1.56%
+2.36%
+3.19%
+1.81%
-2.32%
-0.63%Popular Instruments
FAQs
What is the current price of Cryoport Inc (CYRX)?
The current price of Cryoport Inc (CYRX) is 15.86.
What is the symbol of Cryoport Inc?
The ticker symbol of Cryoport Inc is CYRX.
What is the 52-week high of Cryoport Inc?
The 52-week high of Cryoport Inc is 15.29.
What is the 52-week low of Cryoport Inc?
The 52-week low of Cryoport Inc is 5.31.
What is the market capitalization of Cryoport Inc?
The market capitalization of Cryoport Inc is 796.14M.
Is Cryoport Inc (CYRX) currently rated as Buy, Hold, or Sell?
According to analysts, Cryoport Inc (CYRX) has an overall rating of Buy, with a price target of 15.30.
What is the Earnings Per Share (EPS TTM) of Cryoport Inc (CYRX)?
The Earnings Per Share (EPS TTM) of Cryoport Inc (CYRX) is 1.40.